Sunburn

L12_SUNBURN

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L55 Hospital discharge: ICD-9 — 6927A Cause of death: ICD-10 — L55 Cause of death: ICD-9 — 6927A 2 out of 7 registries used, show all original rules.	74
4. Check minimum number of events None	74
5. Include endpoints None	74
6. Filter based on genotype QC (FinnGen only)	72

Control definitions (FinnGen only)

Control exclude: L12_RADIATIONRELATEDSKIN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L55-L59
Name in latin: Erythema solare

NAME	L12_SUNBURN
CONTROL_EXCLUDE	L12_RADIATIONRELATEDSKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L55
HD_ICD_9	6927A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L55
COD_ICD_9	6927A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sunburn based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	631	298	326
Only index persons	553	272	281
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	37.42	44.67	30.51
Only index persons	36.73	43.53	30.16

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	72	37	35
Unadjusted period prevalence (%)	0.01	0.01	0.02
Median age at first event (years)	44.85	46.71	42.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
74: Matched controls
740

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L55.9

ICD-10 Finland

Sunburn, unspecified

+∞

36.5

L55.0

ICD-10 Finland

Sunburn of first degree

+∞

20.8

L55.8

ICD-10 Finland

Other sunburn

+∞

11.8

L55.1

ICD-10 Finland

Sunburn of second degree

+∞

8.5

6927A

ICD-9 Finland

Contact dermatitis and other eczema, Due to solar radiation[ERYTHEMA SOLARE]

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4.05

5.97

3.1

2.0

16.59

25.16

2.24

(3022948) Iron [Moles/volume] in Serum or Plasma

3.59

5.39

2.9

1.9

10.60

14.31

umol/l

1.91

(40760892) CBC W Ordered Manual Differential panel - Blood

259

2.88

4.67

7.7

6.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3.33

4.53

3.1

1.9

2.30

2.41

g/l

0.32

(3026493) Urate [Moles/volume] in Serum or Plasma

150

2.84

4.42

3.1

2.6

361.24

8429.30

umol/l

1.06

128

(3006315) Basophils [#/volume] in Blood

276

2.76

4.28

7.9

6.0

0.04

e9/l

0.44

252

(3021589) Normoblasts [#/volume] in Blood

250

2.72

4.25

9.8

8.0

0.00

e9/l

0.50

208

(3001604) Monocytes [#/volume] in Blood

277

2.75

4.24

7.9

6.0

0.65

0.55

e9/l

1.41

252

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

155

2.72

4.10

3.3

2.0

406.16

171.33

u/l

0.43

150

(3019198) Lymphocytes [#/volume] in Blood

286

2.61

3.84

7.8

5.9

1.94

1.80

e9/l

0.52

267

(3013115) Eosinophils [#/volume] in Blood

288

2.58

3.76

8.2

5.9

0.21

0.19

e9/l

0.33

267

(3012544) pH of Venous blood

3.54

3.57

6.2

2.5

—

(3000991) Gas panel - Venous blood

3.72

3.35

6.5

5.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3.11

3.29

6.2

3.6

1.04

1.01

mmol/l

0.34

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

8.03

3.11

1.3

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

343

2.41

3.11

11.1

10.1

4.76

4.12

e9/l

1.04

309

(3023368) Bacteria identified in Blood by Culture

138

2.36

2.89

5.5

3.8

—

(3028707) Methadone [Presence] in Urine by Screen method

6.41

2.75

7.0

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

7.55

2.59

2.2

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

219

2.13

2.57

7.7

4.9

1.20

1.21

mmol/l

0.27

207

(3037756) Immunofixation for Serum or Plasma

6.60

2.41

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.55

2.36

1.7

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.38

2.36

2.8

2.9

1.12

0.81

e6/l

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4.18

2.31

11.6

6.4

24.79

24.82

mmol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3.75

2.11

6.1

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

5.27

2.10

1.0

—

(3022145) Colonoscopy Study observation

2.46

2.10

1.1

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.27

2.05

2.9

2.86

2.39

e6/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.32

1.97

3.1

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

142

2.02

1.96

4.6

2.9

0.15

0.43

e6/l

1.02

112

(3037467) Urinalysis macro (dipstick) panel - Urine

381

1.96

1.93

5.6

4.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3.74

1.88

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.38

1.85

3.0

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.38

1.85

3.0

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

555

2.41

1.85

22.5

11.4

80.68

86.89

ml/min/173m2

1.25

457

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2.86

1.78

8.1

6.5

21.96

24.71

mmol/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

181

1.88

1.75

4.4

2.9

—

(4094501) Cardiovascular stress test using bicycle ergometer

4.04

1.74

1.2

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2.32

1.65

2.2

3.0

1.61

1.65

0.08

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

193

1.83

1.64

2.2

1.7

89.86

98.31

pmol/l

0.28

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

102

2.01

1.63

1.7

1.3

0.95

13.71

u/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

426

1.86

1.58

3.2

4.1

14.90

14.79

pmol/l

0.13

399

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.13

1.56

1.9

1.6

—

(3011288) Drugs identified in Urine by Screen method

3.49

1.55

11.4

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3.02

1.54

5.5

3.0

0.63

0.75

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.65

1.49

1.6

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

130

1.86

1.47

1.8

1.6

1.24

0.80

mg/l

0.32

103

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

606

2.50

1.46

26.7

12.1

26.77

21.32

mg/l

0.54

464

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

106

1.92

1.46

6.0

3.1

205.33

257.57

ng/l

—

(3019225) pH of Specimen

2.42

1.46

5.9

3.0

—

(3012516) Albumin [Mass/volume] in Urine

139

1.83

1.45

4.0

3.0

2808.52

503.60

mg/l

0.37

(3016879) Cocaine [Presence] in Urine

2.56

1.43

6.1

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

123

1.86

1.43

2.4

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

148

1.80

1.43

4.9

3.4

5.88

10.20

mg/mmol

0.41

(3022217) INR in Platelet poor plasma by Coagulation assay

255

1.71

1.42

25.0

12.3

1.31

1.19

inr

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.22

1.41

2.5

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.08

1.38

3.4

1.6

—

(3000494) Fungus identified in Specimen by Culture

2.01

1.37

1.3

—

(3025159) Blasts/100 leukocytes in Blood

2.24

1.36

2.7

4.1

—

0.08

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.63

1.33

5.5

3.0

1.30

1.64

—

(3018095) Leukocytes [#/volume] in Urine

186

1.71

1.32

5.3

3.6

118.94

70.28

e6/l

0.18

135

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.09

1.24

3.2

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

180

1.69

1.24

2.4

2.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.74

1.23

1.2

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.01

1.22

9.1

6.1

105.58

103.43

mmol/l

0.93

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

1.19

0.0

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

2.47

1.16

6.1

1.2

—

(3027008) Opiates [Presence] in Urine

2.39

1.14

6.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

2.39

1.14

6.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.06

1.12

1.4

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

158

1.66

1.12

4.8

3.0

77.04

40.10

e6/l

0.23

126

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

203

1.61

1.10

3.7

18.33

53.89

ng/l

0.98

122

(3035350) Ketones [Presence] in Urine by Test strip

271

1.55

1.03

4.1

3.7

0.00

estimate

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.04

1.00

11.3

6.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

273

1.54

0.99

5.8

5.1

0.00

estimate

—

(40761511) CBC panel - Blood by Automated count

640

2.15

0.98

22.1

10.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

104

1.69

0.94

1.8

1.3

37.54

23.63

iu/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.24

0.94

1.0

—

(3009261) Glucose [Presence] in Urine by Test strip

276

1.51

0.93

4.4

3.7

0.00

estimate

—

(3027944) Amphetamines [Presence] in Urine

2.02

0.86

7.0

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.79

0.84

2.3

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.95

0.84

2.5

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

359

1.47

0.83

5.6

4.1

—

621.83

—

(36304419) Bacteria [Presence] in Urine

143

1.55

0.81

5.3

2.8

—

(40758558) Short blood count panel - Blood

152

1.53

0.81

7.7

7.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.64

0.79

1.5

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

534

1.52

0.68

4.9

4.6

1.93

mu/l

0.00

494

(3044889) 12 lead EKG panel

401

1.39

0.63

3.6

3.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.62

0.63

3.0

1.8

—

(3013512) EKG study

133

1.47

0.63

6.6

3.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.61

0.0

2.2

—

4.14

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

116

1.48

0.61

3.9

—

(3029937) Albumin [Presence] in Urine by Test strip

134

1.45

0.60

5.5

3.9

0.00

estimate

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

181

1.39

0.58

3.3

2.9

2.33

2.36

mmol/l

0.34

160

(46235355) HIV 1 and 2 tests - Meaningful Use set

129

1.41

0.52

2.2

1.8

—

(3026008) Bacteria identified in Urine by Culture

168

1.35

0.47

3.7

2.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.44

0.46

3.0

8.3

—

(3003694) ABO and Rh group [Type] in Blood

180

0.73

0.43

1.4

—

(40768804) Tissue Pathology biopsy report

227

1.30

0.43

2.2

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1.60

0.43

1.4

2.4

0.06

0.12

e6/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

637

1.55

0.43

27.2

14.1

80.33

74.97

umol/l

1.11

637

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.41

0.0

1.3

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.41

0.0

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.41

0.0

1.3

—

(40761535) Cells panel - Urine sediment

1.50

0.41

4.0

4.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.41

0.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.41

0.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.41

0.0

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.41

0.40

1.7

1.6

—

(3002256) Pathology report gross observation

1.41

0.40

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.40

0.0

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.50

0.37

1.3

1.9

1.73

6.44

ug/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.50

0.37

2.2

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.38

0.34

3.0

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

160

1.25

0.29

4.4

3.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

539

1.25

0.28

6.5

4.9

39.21

39.74

mmol/mol

0.19

512

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

416

1.21

0.28

3.8

3.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

211

1.20

0.25

5.0

3.7

—

(4200892) Spirometry reversibility

1.30

0.23

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.21

0.0

1.5

—

71.10

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.2

—

19.60

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(4035726) Immunohistochemistry procedure

1.30

0.21

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

2.3

—

6.21

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.27

0.21

2.0

3.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

283

1.16

0.20

2.4

2.3

—

(3042936) Bacteria identified in Isolate by Culture

0.76

0.16

3.0

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

116

1.15

0.10

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

1.07

0.09

1.2

—

(3000492) Spirometry study

1.05

0.08

1.3

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.81

0.08

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

602

0.90

0.07

5.6

4.4

2.75

2.82

mmol/l

0.32

564

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

563

1.05

0.01

5.3

4.0

5.99

5.95

mmol/l

0.09

522

(1761868) Lipid panel - Serum or Plasma

236

0.96

0.00

3.3

2.6

—

(40768797) Stomach Pathology biopsy report

0.95

-0.00

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

3.1

—

14.10

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

0.00

-0.00

0.0

2.1

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

4.9

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.0

—

(3019977) pH of Arterial blood

0.00

-0.00

0.0

4.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.92

-0.00

1.3

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

200.87

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

5.34

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

2.30

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

20.74

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.89

-0.00

1.6

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

4.8

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.2

—

20.72

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

14.36

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.6

—

7.74

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.4

—

1.19

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

0.00

-0.00

0.0

1.2

—

925.20

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

4.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_SUNBURN and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_SUNBURN.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_SUNBURN – Sunburn

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sunburn

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints